39 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... condition #IDSA ... #Meningitis #Antibiotics ... InfectiousDiseases #Pharmacology ... #Management
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... fasciitis #Skin #IDSA ... #Treatment #management ... #antibiotics #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
#IDSA #Meningitis ... #Antibiotics #Antimicrobial ... InfectiousDiseases #Pharmacology ... #Management
Carbapenems - Antibiotics Class Overview

Imipenem/Cilastin, Meropenem, Ertapenem, Doripenem 

Spectrum: Broadest spectrum antibiotics, cover Gram positive, Gram
Carbapenems - Antibiotics ... Class Overview ... , cover Gram positive ... infections #Pharmacology ... #Overview #Carbapenems
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... Parenteral #IV #Antibiotics ... Osteomyelitis #management ... #treatment #pharmacology ... #idsa
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Infections #OIs #HIVAIDS ... #IDSA #management ... #pharmacology
Synercid (Quinupristin/Dalfopristin) (IV) - Antibiotics Class Overview

Mechanism: “Streptogramins”– inhibits sequential steps in ribosomal synthesis
Spectrum: covers MRSA
Dalfopristin) (IV) - Antibiotics ... Class Overview ... Does not cover E.faecalis ... #Pharmacology #Antibiotics ... #Review #Overview
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... Treatment #Regimen #Management ... #Guidelines #pharmacology
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Class Overview ... B for initial management ... #Pharmacology #Antibiotics ... #Review #Overview